BRONCHITOL

This brand name is authorized in Australia, Austria, Croatia, Estonia, Ireland, Lithuania, Poland, Spain, UK.

Active ingredients

The drug BRONCHITOL contains one active pharmaceutical ingredient (API):

1
UNII 3OWL53L36A - MANNITOL
 

Mannitol is a naturally occurring sugar alcohol used clinically primarily for its osmotic diuretic properties.
 
Read more about Mannitol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BRONCHITOL Inhalation powder, hard capsule MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05CB16 R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 2008Q, 2015C
EE Ravimiamet 1566479, 1566480
ES Centro de información online de medicamentos de la AEMPS 112760
GB Medicines & Healthcare Products Regulatory Agency 205149, 205154
LT Valstybinė vaistų kontrolės tarnyba 1066062, 1066063
PL Rejestru Produktów Leczniczych 100308812

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈